On Tuesday, ACM Research Cl A received a positive adjustment to its Relative Strength (RS) Rating, from 78 to 84.
Hone Your Stock-Picking Skills By Focusing On These Factors
IBD's proprietary rating tracks market leadership with a 1 (worst) to 99 (best) score. The grade shows how a stock's price movement over the trailing 52 weeks holds up against all the other stocks in our database.
Decades of market research shows that the stocks that go on to make the biggest gains tend to have an RS Rating of at least 80 as they launch their biggest price moves.
ACM Research Cl A is working on a cup with handle with a 25.61 entry. See if the stock can clear the breakout price in volume at least 40% above average. Keep in mind that it's a later-stage consolidation, and those entail more risk.
ACM Research Cl A reported -12% earnings growth in its most recent report. Revenue gains came in at 13%.
The company holds the No. 3 rank among its peers in the Electronics-Semiconductor Equipment industry group. KLA is the No. 1-ranked stock within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
Stocks With Rising Relative Strength Ratings
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
